NEW YORK (Reuters) - Buyout firm Carlyle Group struck a deal to acquire medical-device maker Baxter’s kidney-care unit ... reported Carlyle's talks to acquire the Vantive unit in July.
The company has faced pressure from shareholder activists to divest the Worldpac unit to better compete with AutoZone and ...
Kidney care accounted for about a third of Baxter’s revenue last year. The transaction is expected to close in late 2024 or early 2025. Baxter shares rose 0.2% before US markets opened.
Baxter International Inc. said it will sell its kidney-care unit to the Carlyle Group private equity firm for $3.8 billion, part of the health care company’s efforts to streamline and pay down debt.
Baxter's kidney-care operations generated about $4.5 billion in revenue last year and has more than 23,000 employees. The Wall Street Journal reported Carlyle's talks to acquire the Vantive unit ...